CNST - Constellation Pharmaceuticals EPS misses by $0.02 October, 29 2020 07:11 AM Constellation Pharmaceuticals Inc. Constellation Pharmaceuticals (CNST): Q3 GAAP EPS of -$0.71 misses by $0.02.Cash equivalents and marketable securities of $489.4M.Press Release For further details see: Constellation Pharmaceuticals EPS misses by $0.02